Intuitive Surgical, Inc. $ISRG Shares Sold by Elite Wealth Management Inc.

Elite Wealth Management Inc. lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 96.3% during the 1st quarter, Holdings Channel reports. The firm owned 596 shares of the medical equipment provider’s stock after selling 15,589 shares during the quarter. Elite Wealth Management Inc.’s holdings in Intuitive Surgical were worth $275,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the stock. Prosperity Consulting Group LLC lifted its position in Intuitive Surgical by 0.5% during the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after acquiring an additional 19 shares during the period. Sunburst Financial Group LLC increased its holdings in shares of Intuitive Surgical by 4.3% in the fourth quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 20 shares during the period. WoodTrust Financial Corp raised its stake in shares of Intuitive Surgical by 0.5% in the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock worth $2,367,000 after purchasing an additional 20 shares during the last quarter. North Star Investment Management Corp. lifted its holdings in shares of Intuitive Surgical by 8.5% during the fourth quarter. North Star Investment Management Corp. now owns 269 shares of the medical equipment provider’s stock worth $152,000 after purchasing an additional 21 shares during the period. Finally, Cornerstone Planning Group LLC lifted its holdings in shares of Intuitive Surgical by 11.5% during the fourth quarter. Cornerstone Planning Group LLC now owns 203 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 21 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several research reports. Citigroup cut their price target on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a report on Friday, July 17th. Bank of America dropped their price objective on shares of Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. TD Cowen cut their price objective on shares of Intuitive Surgical from $585.00 to $520.00 and set a “buy” rating on the stock in a research note on Monday, July 13th. Sanford C. Bernstein reduced their target price on shares of Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating for the company in a report on Friday, July 17th. Finally, The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Twenty-one analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $519.13.

Insider Activity at Intuitive Surgical

In related news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This represents a 46.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,669 shares of company stock worth $2,822,405 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $356.83 on Tuesday. The firm has a market cap of $126.06 billion, a PE ratio of 40.87, a P/E/G ratio of 2.44 and a beta of 1.46. The firm’s fifty day moving average is $405.22 and its 200 day moving average is $457.57. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the prior year, the firm posted $1.81 earnings per share. The company’s revenue was up 18.4% compared to the same quarter last year. Research analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.